Clinical Trial

French Parkinson's Disease Cohort - NS-PARK

Study acronym: NS-PARK
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of NS-PARK cohort are to describe the natural history of Parkinson's disease (PD), and to propose patients stratification models based on PD pathophysiological mechanisms. Patients are included at all PD expert centers in France. Standardized demographic, diagnosis, motor and non-motor symptoms evaluation, and treatment information are collected, and clinical data are updated at each visit of the patient at the center. A blood sampling is perform at baseline for genetic testing and implement an associated biocollection.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-05-11; most recent amendment 2025-01-10.
Status change: Not Yet Recruiting → Recruiting 2021-08-25
Trial Details
NCT Number NCT04888364
Lead Sponsor Institut National de la Santé Et de la Recherche Médicale, France
Conditions Parkinson Disease
Enrollment 30,000 participants
Start Date 2021-06-16
Primary Completion 2028-06-30 (estimated)
Study Completion 2030-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-01-13